Mike Pisetsky serves as the General Counsel and Chief Administrative Officer at SI-BONE, a leading orthopedic implant manufacturer dedicated to transforming the treatment of musculoskeletal disorders. In his multifaceted role, Mike is instrumental in steering the company through complex legal landscapes while ensuring robust administrative...
Mike Pisetsky serves as the General Counsel and Chief Administrative Officer at SI-BONE, a leading orthopedic implant manufacturer dedicated to transforming the treatment of musculoskeletal disorders. In his multifaceted role, Mike is instrumental in steering the company through complex legal landscapes while ensuring robust administrative support that aligns with SI-BONE’s strategic objectives. His extensive experience in corporate law and regulatory compliance allows him to adeptly navigate the intricate legal frameworks governing the life sciences and medical device industries.
One of Mike's significant achievements includes managing the legal process for SI-BONE's successful $124 million initial public offering in October 2018, followed by a $106 million follow-on offering in January 2020, and a subsequent $72 million follow-on offering. These milestones not only reflect his expertise in corporate finance and venture financing but also underscore his ability to guide companies through critical growth phases, from inception to public market entry.
In addition to his IPO experience, Mike provides strategic counsel on a wide array of legal and regulatory matters, including employment law, compliance issues, intellectual property rights, and commercial agreements. His proactive approach to legal challenges empowers SI-BONE to forge strategic partnerships and pursue new business development opportunities, ensuring that the company remains at the forefront of innovation in the orthopedic space. With a keen understanding of the unique challenges faced by start-ups and established firms alike, Mike is committed to fostering a culture of compliance and ethical business practices that drive sustainable growth and success in the competitive landscape of implantable medical devices.
